The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Genetically resistant mice lacking interleukin‐12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
Abstract
Mice with homologous disruption of the gene coding for either the p35 subunit or the p40 subunit of interleukin‐12 (IL‐12) and derived from a strain genetically resistant to infection with Leishmania major have been used to study further the role of this cytokine in resistance to infection and the differentiation of functional CD4+ T cell subsets in vivo. Wild‐type 129/Sv/Ev mice are resistant to infection with L. major showing only small lesions which resolve spontaneously within a few weeks and develop a type 1 CD4+ T cell response. In contrast, mice lacking bioactive IL‐12 (IL‐12p35−/− and IL‐12p40−/−) developed large, progressing lesions. Whereas resistant mice were able to mount a delayed‐type hypersensitivity (DTH) response to Leishmania antigen, susceptible BALB/c mice as well as IL‐12‐deficient 129/Sv/Ev mice did not show any DTH reaction. To characterize the functional phenotype of CD4+ T cells triggered in infected wild‐type mice and IL‐12‐deficient mice, the expression of mRNA for interferon‐γ (IFN‐γ) and interleukin‐4 (IL‐4) in purified CD4+ lymph node cells was analyzed. Wild‐type 129/Sv/Ev mice showed high levels of mRNA for IFN‐γ and low levels of mRNA for IL‐4 which is indicative of a Th1 response. In contrast, IL‐12‐ deficient mice and susceptible BALB/c mice developed a strong Th2 response with high levels of IL‐4 mRNA and low levels of IFN‐γ mRNA in CD4+ T cells. Similarly, lymph node cells from infected wild‐type 129 mice produced predominantly IFN‐γ in response to stimulation with Leishmania antigen in vitro whereas lymph node cells from IL‐12‐deficient mice and susceptible BALB/c mice produced preferentially IL‐4. Taken together, these results confirm in vivo the importance of IL‐12 in induction of Th1 responses and protective immunity against L. major.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,494
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454
Current protocols in immunology
Nezlin, R. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,408
The Regulation of Immunity to Leishmania major
Reiner, S. L. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.151 · Cited by 1,297
Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody
Springer, T., Galfré, G., Secher, D. S., & Milstein, C. (1979) · European Journal of Immunology · doi:10.1002/eji.1830090410 · Cited by 1,107
Cherwinski, H. M., Schumacher, J. H., Brown, K. D., & Mosmann, T. R. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1229 · Cited by 1,036
Cited by
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Self-citationThe immunology of susceptibility and resistance to Leishmania major in mice
Sacks, D., & Noben-Trauth, N. (2002) · Nature Reviews Immunology · doi:10.1038/nri933 · Cited by 1,208
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
Hunter, C. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1648 · Cited by 852
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80378-7 · Cited by 720
The biology of IL-12: coordinating innate and adaptive immune responses
Watford, W. T., Moriguchi, M., Morinobu, A., & O’Shea, J. J. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00043-1 · Cited by 576
Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4
Watford, W. T., Hissong, B. D., Bream, J. H., Kanno, Y., Muul, L., & O'Shea, J. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00211.x · Cited by 572
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
The Immunobiology of the Interleukin-12 Family: Room for Discovery
Tait Wojno, E. D., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 482
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B. M., Dwyer, B. K., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 469
Happel, K. I., Zheng, M., Young, E., Quinton, L. J., Lockhart, E., Ramsay, A. J., Shellito, J. E., Schurr, J. R., Bagby, G. J., Nelson, S., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4432 · Cited by 449
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kälin, R. E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C. G., Peters, O., et al. (2012) · Nature Medicine · doi:10.1038/nm.2965 · Cited by 416
WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection
Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00206-0 · Cited by 406
Gran, B., Zhang, G.-X., Yu, S., Li, J., Chen, X.-H., Ventura, E. S., Kamoun, M., & Rostami, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.7104 · Cited by 405
Agnello, D., Lankford, C. S. R., Bream, J., Morinobu, A., Gadina, M., O'Shea, J. J., & Frucht, D. M. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1023381027062 · Cited by 378
Hochrein, H., O'Keeffe, M., Luft, T., Vandenabeele, S., Grumont, R. J., Maraskovsky, E., & Shortman, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.823 · Cited by 368
Hou, B., Reizis, B., & DeFranco, A. L. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.016 · Cited by 363
Multistage Regulation of Th1-Type Immune Responses by the Transcription Factor IRF-1
Taki, S., Sato, T., Ogasawara, K., Fukuda, T., Sato, M., Hida, S., Suzuki, G., Mitsuyama, M., Shin, E.-H., Kojima, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80443-4 · Cited by 353
The IL-12 Family of Cytokines in Infection, Inflammation and Autoimmune Disorders
Gee, K., Guzzo, C., Che Mat, N., Ma, W., & Kumar, A. (2009) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152809787582507 · Cited by 356
Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation
Sutterwala, F. S., Noel, G. J., Clynes, R., & Mosser, D. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1977 · Cited by 351
Biologic therapy of inflammatory bowel disease
Sandborn, W. J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.33426 · Cited by 344
IL-12p40: an inherently agonistic cytokine
Cooper, A. M., & Khader, S. A. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.002 · Cited by 344
Dynamic balance of pro‐ and anti‐inflammatory signals controls disease and limits pathology
Cicchese, J. M., Evans, S., Hult, C., Joslyn, L. R., Wessler, T., Millar, J. A., Marino, S., Cilfone, N. A., Mattila, J. T., Linderman, J. J., et al. (2018) · Immunological Reviews · doi:10.1111/imr.12671 · Cited by 343
Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency
Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante, J., Breiman, A., Altare, F., Baretto, R., Le Deist, F., Kayal, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021769 · Cited by 312
Decken, K., Köhler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K., & Alber, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4994-5000.1998 · Cited by 311
Self-citationCooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J., & Orme, I. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1322 · Cited by 304
Self-citationLaunois, P., Maillard, I., Pingel, S., Swihart, K. G., Xénarios, I., Acha-Orbea, H., Diggelmann, H., Locksley, R. M., MacDonald, H. R., & Louis, J. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80342-8 · Cited by 302
Self-citationThe immune response to Leishmania: mechanisms of parasite control and evasion
Bogdan, C., & Röllinghoff, M. (1998) · International Journal for Parasitology · doi:10.1016/s0020-7519(97)00169-0 · Cited by 292
Tacchini-Cottier, F., Zweifel, C., Belkaid, Y., Mukankundiye, C., Vasei, M., Launois, P., Milon, G., & Louis, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2628 · Cited by 291
Self-citationCousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R., & Biron, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1315 · Cited by 290
Type I IFN Modulates Innate and Specific Antiviral Immunity
Durbin, J. E., Fernandez-Sesma, A., Lee, C.-K., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanovic, S., García-Sastre, A., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4220 · Cited by 286
Picard, C., Fieschi, C., Altare, F., Al-Jumaah, S., Al-Hajjar, S., Feinberg, J., Dupuis, S., Soudais, C., Al-Mohsen, I. Z., Génin, E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338625 · Cited by 282
Hölscher, C., Hölscher, A., Rückerl, D., Yoshimoto, T., Yoshida, H., Mak, T., Saris, C., & Ehlers, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3534 · Cited by 279
Sellers, R. S., Clifford, C. B., Treuting, P. M., & Brayton, C. (2012) · Veterinary Pathology · doi:10.1177/0300985811429314 · Cited by 278
“major.(99) Although IL-12 treatment in BALB/c mice does reduce susceptibility to L.”
BackgroundGorak, P. M. A., Engwerda, C. R., & Kaye, P. M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<687::aid-immu687>3.0.co;2-n · Cited by 277
Sato, N., Ahuja, S. K., Quinones, M., Kostecki, V., Reddick, R. L., Melby, P. C., Kuziel, W. A., & Ahuja, S. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.205 · Cited by 270
Developmental and Functional Control of Natural Killer Cells by Cytokines
Wu, Y., Tian, Z., & Wei, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00930 · Cited by 269
Novel IL-12 family members shed light on the orchestration of Th1 responses
Brombacher, F. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00067-x · Cited by 269
Interleukin‐35: odd one out or part of the family?
Collison, L. W., & Vignali, D. A. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00704.x · Cited by 260
Su, Z., & Stevenson, M. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4399-4406.2000 · Cited by 260
Mechanisms of Immune Evasion in Leishmaniasis
Gupta, G., Oghumu, S., & Satoskar, A. R. (2013) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-407679-2.00005-3 · Cited by 259
Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252
Doolan, D. L., & Hoffman, S. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.884 · Cited by 183
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136
Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.261 · Cited by 133
IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119
Padigel, U. M., Kim, N., Choi, Y., & Farrell, J. P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5437 · Cited by 36
“The development of a dominant Th1 response is dependent upon the proinflammatory cytokine IL-12 as evidenced by the inability of animals lacking the IL-12 gene (4) or mice treated with Ab to IL-12 (5, 6) to resolve infection, and by the demonstration that treatment with recombinant IL-12 promotes healing in highly sus…”
Background
Metadata
- Authors
- Mattner, F., Magram, J., Ferrante, J., Launois, P., Padova, K. D., Behin, R., Gately, M. K., Louis, J. A., & Alber, G.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1996-07
- Volume
- 26
- Issue
- 7
- Pages
- 1553-1559
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2017684091
- Cited by
- 469
- References
- 33
- FWCI
- 45.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.